{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:08:14Z","timestamp":1789218494952,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004722","name":"Lars Hierta Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009252","name":"SciLifeLab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004785","name":"Nordforsk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"Sweden's Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Colloid and Interface Science"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jcis.2026.141012","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:46:53Z","timestamp":1782431213000},"page":"141012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Double emulsions enable in situ generation of permeation enhancers for oral delivery of macromolecules"],"prefix":"10.1016","volume":"724","author":[{"given":"Hannah","family":"Pohlit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela Isabel","family":"Bini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristhian Fernando","family":"Salas Cotaquispe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Sikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel A.S.","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakhawath","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Brayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Teleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jcis.2026.141012_bb0005","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jcis.2026.141012_bb0010","author":"Grand View Research"},{"issue":"7","key":"10.1016\/j.jcis.2026.141012_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tips.2023.04.003","article-title":"Recent advances in the development of therapeutic peptides","volume":"44","author":"Fetse","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jcis.2026.141012_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114097","article-title":"Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers","volume":"182","author":"Haddadzadegan","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.jcis.2026.141012_bb0025","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","article-title":"Oral delivery of proteins and peptides: challenges, status quo and future perspectives","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm Sin B."},{"issue":"1","key":"10.1016\/j.jcis.2026.141012_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010047","article-title":"Oral absorption of middle-to-large molecules and its improvement, with a focus on new modality drugs","volume":"16","author":"Asano","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jcis.2026.141012_bb0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2018.08.032","article-title":"Oral peptide delivery: translational challenges due to physiological effects","volume":"287","author":"Tyagi","year":"2018","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jcis.2026.141012_bb0040","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.apsb.2019.01.004","article-title":"Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides\/proteins","volume":"9","author":"Han","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.jcis.2026.141012_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ph15121585","article-title":"Gastrointestinal permeation enhancers for the development of Oral peptide pharmaceuticals","volume":"15","author":"Kim","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"10.1016\/j.jcis.2026.141012_bb0050","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1021\/acs.molpharmaceut.0c00668","article-title":"Influence of bile composition on membrane incorporation of transient permeability enhancers","volume":"17","author":"Hossain","year":"2020","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.jcis.2026.141012_bb0055","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/anie.202011931","article-title":"TIRF microscopy-based monitoring of drug permeation across a lipid membrane supported on mesoporous silica","volume":"60","author":"Joyce","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.jcis.2026.141012_bb0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/acs.molpharmaceut.1c00689","article-title":"In silico-based experiments on mechanistic interactions between several intestinal permeation enhancers with a lipid bilayer model","volume":"19","author":"Kneiszl","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jcis.2026.141012_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122238","article-title":"Considerations in the developability of peptides for oral administration when formulated together with transient permeation enhancers","volume":"628","author":"Berg","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jcis.2026.141012_bb0070","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.ddtec.2011.11.006","article-title":"Overcoming poor permeability: translating permeation enhancers for oral peptide delivery","volume":"9","author":"Maher","year":"2012","journal-title":"Drug Discov. Today Technol."},{"issue":"2","key":"10.1016\/j.jcis.2026.141012_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/17425247.2021.1825375","article-title":"Intestinal permeation enhancers to improve oral bioavailability of macromolecules: reasons for low efficacy in humans","volume":"18","author":"Maher","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"issue":"Pt 1","key":"10.1016\/j.jcis.2026.141012_bb0080","article-title":"Pickering double emulsions stabilized by acylated cellulose nanocrystals for oral co-delivery of macromolecules and permeation enhancers","volume":"700","author":"Bertsch","year":"2025","journal-title":"J. Colloid Interface Sci."},{"issue":"2","key":"10.1016\/j.jcis.2026.141012_bb0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2015.10.057","article-title":"Double emulsion solvent evaporation techniques used for drug encapsulation","volume":"496","author":"Iqbal","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jcis.2026.141012_bb0090","series-title":"Oral Delivery of Macromolecules Formulated with Permeation Enhancers","author":"Berg","year":"2022"},{"issue":"12","key":"10.1016\/j.jcis.2026.141012_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122844","article-title":"Dietary-polysaccharide-modified fish-oil-based double emulsion as a functional colloidal formulation for Oral drug delivery","volume":"14","author":"Li","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jcis.2026.141012_bb0100","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00396-003-0960-8","article-title":"Improved formulation of W\/O\/W multiple emulsion for insulin encapsulation. Influence of the chemical structure of insulin","volume":"282","author":"Vauthier","year":"2004","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.jcis.2026.141012_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2018.12.037","article-title":"Double emulsions prepared by two-step emulsification: history, state-of-the-art and perspective","volume":"295","author":"Ding","year":"2019","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jcis.2026.141012_bb0110","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/1541-4337.12261","article-title":"Double emulsions relevant to food systems: preparation, stability, and applications","volume":"16","author":"Muschiolik","year":"2017","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"issue":"5","key":"10.1016\/j.jcis.2026.141012_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/foods12050992","article-title":"Recent advances in Pickering double emulsions and potential applications in functional foods: a perspective paper","volume":"12","author":"Zhang","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.jcis.2026.141012_bb0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tifs.2022.07.016","article-title":"New insights into water-in-oil-in-water (W\/O\/W) double emulsions: properties, fabrication, instability mechanism, and food applications","volume":"128","author":"Kumar","year":"2022","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.jcis.2026.141012_bb0125","series-title":"Nanoemulsions: An Emerging Technology in Drug Delivery","first-page":"381","author":"Rafique","year":"2021"},{"issue":"3","key":"10.1016\/j.jcis.2026.141012_bb0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1039\/B916318B","article-title":"Microfluidic preparation of water-in-oil-in-water emulsions with an ultra-thin oil phase layer","volume":"10","author":"Saeki","year":"2010","journal-title":"Lab Chip"},{"issue":"5","key":"10.1016\/j.jcis.2026.141012_bb0135","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s13346-022-01246-y","article-title":"Intrinsic lipolysis rate for systematic design of lipid-based formulations","volume":"13","author":"Jacobsen","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.jcis.2026.141012_bb0140","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jcis.2026.141012_bb0145","author":"The 3Rs"},{"issue":"6","key":"10.1016\/j.jcis.2026.141012_bb0150","doi-asserted-by":"crossref","first-page":"G1151","DOI":"10.1152\/ajpgi.90649.2008","article-title":"A guide to Ussing chamber studies of mouse intestine","volume":"296","author":"Clarke","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.jcis.2026.141012_bb0155","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2885.2010.01218.x","article-title":"Feasibility of the Ussing chamber technique for the determination of in vitro jejunal permeability of passively absorbed compounds in different animal species","volume":"34","author":"Neirinckx","year":"2011","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.jcis.2026.141012_bb0160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejps.2016.10.006","article-title":"Prediction of drug intestinal absorption in human using the Ussing chamber system: a comparison of intestinal tissues from animals and humans","volume":"96","author":"Miyake","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jcis.2026.141012_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105685","article-title":"Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C(10)): isolated rat intestinal mucosae and sacs","volume":"158","author":"Twarog","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jcis.2026.141012_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102801","article-title":"Acid-tolerant and hypoxia-responsive drug delivery system based on sulphobetaine-modified azocalix[4]arene for treating ulcerative colitis","volume":"64","author":"Liu","year":"2025","journal-title":"Nano Today"},{"issue":"9","key":"10.1016\/j.jcis.2026.141012_bb0175","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/jps.23205","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations","volume":"101","author":"Williams","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.jcis.2026.141012_bb0180","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.jcis.2026.141012_bb0185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejps.2009.09.001","article-title":"Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae","volume":"38","author":"Maher","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jcis.2026.141012_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126315","article-title":"Capryol(R) 90 is an efficacious intestinal absorption enhancer for insulin in vivo when combined other excipients","volume":"686","author":"McCartney","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.jcis.2026.141012_bb0195","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41592-021-01098-3","article-title":"Martini 3: a general purpose force field for coarse-grained molecular dynamics","volume":"18","author":"Souza","year":"2021","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.jcis.2026.141012_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/pr10010029","article-title":"Explicit-pH coarse-grained molecular dynamics simulations enable insights into restructuring of intestinal colloidal aggregates with permeation enhancers","volume":"10","author":"Hossain","year":"2021","journal-title":"Processes"},{"issue":"9","key":"10.1016\/j.jcis.2026.141012_bb0205","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/acscentsci.5c00755","article-title":"The martini 3 lipidome: expanded and refined parameters improve lipid phase behavior","volume":"11","author":"Pedersen","year":"2025","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jcis.2026.141012_bb0210","series-title":"Martinize2 and Vermouth: Unified Framework for Topology Generation","author":"Kroon","year":"2025"},{"issue":"47","key":"10.1016\/j.jcis.2026.141012_bb0215","doi-asserted-by":"crossref","first-page":"19180","DOI":"10.1039\/D3NR05571J","article-title":"Revealing the interaction between peptide drugs and permeation enhancers in the presence of intestinal bile salts","volume":"15","author":"Hossain","year":"2023","journal-title":"Nanoscale"},{"issue":"12","key":"10.1016\/j.jcis.2026.141012_bb0220","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1021\/acs.jctc.2c00757","article-title":"Martini 3 coarse-grained force field for carbohydrates","volume":"18","author":"Grunewald","year":"2022","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"10.1016\/j.jcis.2026.141012_bb0225","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41467-021-27627-4","article-title":"Polyply; a python suite for facilitating simulations of macromolecules and nanomaterials","volume":"13","author":"Grunewald","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jcis.2026.141012_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"1","key":"10.1016\/j.jcis.2026.141012_bb0235","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.jcis.2026.141012_bb0240","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.jcis.2026.141012_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106524","article-title":"Exploring the use of modified in vitro digestion assays for the evaluation of ritonavir loaded solid lipid-based formulations","volume":"189","author":"Andreadis","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jcis.2026.141012_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11010041","article-title":"Application of permeation enhancers in Oral delivery of macromolecules: an update","volume":"11","author":"Maher","year":"2019","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.jcis.2026.141012_bb0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11095-017-2327-8","article-title":"Caco-2 cell conditions enabling studies of drug absorption from digestible lipid-based formulations","volume":"35","author":"Keemink","year":"2018","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jcis.2026.141012_bb0260","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.xphs.2020.10.061","article-title":"Molecular dynamics simulations reveal membrane interactions for poorly water-soluble drugs: impact of bile solubilization and drug aggregation","volume":"110","author":"Kabedev","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jcis.2026.141012_bb0265","doi-asserted-by":"crossref","DOI":"10.1039\/D6CP00414H","article-title":"Aggregation behavior of sodium caprate under different pH, concentration, and intestinal fluid conditions: a coarse-grained molecular dynamics study comparing martini 2 and martini 3","author":"Akter","year":"2026","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"2","key":"10.1016\/j.jcis.2026.141012_bb0270","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0022-3565(25)12150-2","article-title":"Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers","volume":"275","author":"Lindmark","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.jcis.2026.141012_bb0275","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/03639045.2012.692376","article-title":"The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line","volume":"39","author":"Yu","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"9","key":"10.1016\/j.jcis.2026.141012_bb0280","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/all.15825","article-title":"Mechanisms of gut epithelial barrier impairment caused by food emulsifiers polysorbate 20 and polysorbate 80","volume":"78","author":"Ogulur","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jcis.2026.141012_bb0285","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2019.08.008","article-title":"Labrasol(R) is an efficacious intestinal permeation enhancer across rat intestine: ex vivo and in vivo rat studies","volume":"310","author":"McCartney","year":"2019","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jcis.2026.141012_bb0290","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.xphs.2024.10.021","article-title":"Characterization of macrocyclic peptide drug interactions with bile salts and biorelevant colloids via single amino acid mutations and (1)H nuclear magnetic resonance (NMR) spectroscopy","volume":"114","author":"Dening","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jcis.2026.141012_bb0295","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jconrel.2022.12.011","article-title":"Evaluation in pig of an intestinal administration device for oral peptide delivery","volume":"353","author":"Berg","year":"2023","journal-title":"J. Control. Release"}],"container-title":["Journal of Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979726011896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979726011896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:00:07Z","timestamp":1789218007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021979726011896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":59,"alternative-id":["S0021979726011896"],"URL":"https:\/\/doi.org\/10.1016\/j.jcis.2026.141012","relation":{},"ISSN":["0021-9797"],"issn-type":[{"value":"0021-9797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Double emulsions enable in situ generation of permeation enhancers for oral delivery of macromolecules","name":"articletitle","label":"Article Title"},{"value":"Journal of Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcis.2026.141012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"141012"}}